In-licensing: Semi modern cancer drugs and adjunctive products for cancer

Latest: Watch here for details of new products and services.

Our Products: Overview; Partnering Search; Company Profiling; Partneringtools; Reports; Partnering Consulting; Comparison
Forums: Visit our forums
Jobs: Visit our job site
Case Studies: See what others think about our service
Newsletter: Partnering update; Key reports; Subscribe
Quick Links: Profile now; Register now; Profiled companies; Featured events; Industry news; PR Newswire New!
Contact us: Send an email; Call us: +44 1904 520460; Request a callback
RSS Feeds: Keep up to date

Pharmalicensing Ltd
is a division of

We are looking for semi modern cancer drugs and adjunctive products for cancer

We are looking for semi modern cancer drugs-antineoplastics (EPH 3 group L01X)

And adjunctive products for cancer inparticular immunostimulating agents, new antiemetics, immunosuppressive agents

Preregistration

In-licensing opportunities with exclusive rights to market and sell the product in Finland

Raimo Skottman
Business Development Director

For more information about the product please visit website.

Leiras Finland
Finnish pharmaceutical company having business interest in Rx, OTC and generics area

Are you looking for reports related to this particular subject. Our Reports section is the best place to start.

Industry sector: Biotechnology; Pharmaceutical; Pharmaceutical / Prescription; Pharmaceutical / Generics
Therapeutic target: Immune related disorders; Immune related disorders / Immunostimulation; Immune related disorders / Immunosuppression; Oncology; Oncology / Brain cancer; Oncology / Breast cancer; Oncology / Lung cancer; Oncology / Prostate cancer; Oncology / Skin cancer

Industry news: Pharmalicensing provides comprehensive industry coverage.